

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.69093825 |
| 2 | maturation of SSU-rRNA (GO:0030490) | 4.66661049 |
| 3 | ribosomal small subunit assembly (GO:0000028) | 4.64792611 |
| 4 | nucleobase biosynthetic process (GO:0046112) | 4.58425967 |
| 5 | DNA replication initiation (GO:0006270) | 4.56992669 |
| 6 | formation of translation preinitiation complex (GO:0001731) | 4.52796131 |
| 7 | DNA deamination (GO:0045006) | 4.47256045 |
| 8 | DNA strand elongation (GO:0022616) | 4.42863969 |
| 9 | DNA unwinding involved in DNA replication (GO:0006268) | 4.39273137 |
| 10 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.38526136 |
| 11 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.36987397 |
| 12 | GDP-mannose metabolic process (GO:0019673) | 4.33791216 |
| 13 | purine nucleobase biosynthetic process (GO:0009113) | 4.33367243 |
| 14 | ribosome biogenesis (GO:0042254) | 4.23789192 |
| 15 | viral transcription (GO:0019083) | 4.23462437 |
| 16 | translational termination (GO:0006415) | 4.19737416 |
| 17 | ribonucleoprotein complex biogenesis (GO:0022613) | 4.05118852 |
| 18 | IMP biosynthetic process (GO:0006188) | 4.01503424 |
| 19 | ribosomal large subunit biogenesis (GO:0042273) | 3.99972147 |
| 20 | telomere maintenance via recombination (GO:0000722) | 3.89327338 |
| 21 | ribosome assembly (GO:0042255) | 3.89122915 |
| 22 | translational elongation (GO:0006414) | 3.88842569 |
| 23 | ribosomal small subunit biogenesis (GO:0042274) | 3.87148757 |
| 24 | translational initiation (GO:0006413) | 3.84400036 |
| 25 | DNA replication checkpoint (GO:0000076) | 3.81823028 |
| 26 | mitotic nuclear envelope disassembly (GO:0007077) | 3.72115707 |
| 27 | mitotic metaphase plate congression (GO:0007080) | 3.71987168 |
| 28 | protein localization to kinetochore (GO:0034501) | 3.70834420 |
| 29 | proteasome assembly (GO:0043248) | 3.67214715 |
| 30 | IMP metabolic process (GO:0046040) | 3.64929940 |
| 31 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.63378108 |
| 32 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.63378108 |
| 33 | * rRNA processing (GO:0006364) | 3.61938943 |
| 34 | mitotic recombination (GO:0006312) | 3.59769271 |
| 35 | regulation of translational termination (GO:0006449) | 3.58467483 |
| 36 | pseudouridine synthesis (GO:0001522) | 3.57912856 |
| 37 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.54350116 |
| 38 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.53490730 |
| 39 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.52019876 |
| 40 | spliceosomal snRNP assembly (GO:0000387) | 3.51669502 |
| 41 | * rRNA metabolic process (GO:0016072) | 3.49350563 |
| 42 | telomere maintenance via telomere lengthening (GO:0010833) | 3.46806019 |
| 43 | folic acid metabolic process (GO:0046655) | 3.45770870 |
| 44 | cotranslational protein targeting to membrane (GO:0006613) | 3.42365094 |
| 45 | protein targeting to ER (GO:0045047) | 3.41244637 |
| 46 | CENP-A containing nucleosome assembly (GO:0034080) | 3.39733458 |
| 47 | nuclear envelope disassembly (GO:0051081) | 3.39550223 |
| 48 | membrane disassembly (GO:0030397) | 3.39550223 |
| 49 | positive regulation of defense response to virus by host (GO:0002230) | 3.38872632 |
| 50 | chromatin remodeling at centromere (GO:0031055) | 3.33935629 |
| 51 | necroptotic process (GO:0070266) | 3.31621114 |
| 52 | cellular protein complex disassembly (GO:0043624) | 3.31284025 |
| 53 | viral life cycle (GO:0019058) | 3.28422869 |
| 54 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.27119386 |
| 55 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.26319996 |
| 56 | nuclear pore organization (GO:0006999) | 3.25657021 |
| 57 | protein localization to chromosome, centromeric region (GO:0071459) | 3.25106553 |
| 58 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.24925271 |
| 59 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.22835342 |
| 60 | protein localization to endoplasmic reticulum (GO:0070972) | 3.21958828 |
| 61 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.21261611 |
| 62 | metaphase plate congression (GO:0051310) | 3.19132141 |
| 63 | cellular response to exogenous dsRNA (GO:0071360) | 3.17498715 |
| 64 | interferon-gamma production (GO:0032609) | 3.17440646 |
| 65 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.16937804 |
| 66 | rRNA modification (GO:0000154) | 3.16608481 |
| 67 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.13919221 |
| 68 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.13131625 |
| 69 | translation (GO:0006412) | 3.12505301 |
| 70 | DNA replication-independent nucleosome organization (GO:0034724) | 3.12438209 |
| 71 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.12438209 |
| 72 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.11630768 |
| 73 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.11025671 |
| 74 | cellular component biogenesis (GO:0044085) | 3.09321512 |
| 75 | regulation of defense response to virus by host (GO:0050691) | 3.08329889 |
| 76 | establishment of integrated proviral latency (GO:0075713) | 3.02322099 |
| 77 | tolerance induction (GO:0002507) | 3.01565333 |
| 78 | cell cycle G1/S phase transition (GO:0044843) | 3.00342598 |
| 79 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.00342598 |
| 80 | negative regulation of ligase activity (GO:0051352) | 3.00166812 |
| 81 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.00166812 |
| 82 | programmed necrotic cell death (GO:0097300) | 2.98631814 |
| 83 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.98599375 |
| 84 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.98432374 |
| 85 | protein complex disassembly (GO:0043241) | 2.97611164 |
| 86 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.97022111 |
| 87 | nuclear pore complex assembly (GO:0051292) | 2.96786432 |
| 88 | termination of RNA polymerase III transcription (GO:0006386) | 2.96046412 |
| 89 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.96046412 |
| 90 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.95218699 |
| 91 | maturation of 5.8S rRNA (GO:0000460) | 2.95118960 |
| 92 | leukocyte aggregation (GO:0070486) | 2.93072482 |
| 93 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.89491814 |
| 94 | hepatocyte apoptotic process (GO:0097284) | 2.87540207 |
| 95 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.87056202 |
| 96 | establishment of chromosome localization (GO:0051303) | 2.86542328 |
| 97 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.86518705 |
| 98 | spliceosomal complex assembly (GO:0000245) | 2.86177033 |
| 99 | regulation of spindle organization (GO:0090224) | 2.85463099 |
| 100 | negative thymic T cell selection (GO:0045060) | 2.84856805 |
| 101 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.84030665 |
| 102 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.84030665 |
| 103 | kinetochore organization (GO:0051383) | 2.83960382 |
| 104 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.82663017 |
| 105 | DNA duplex unwinding (GO:0032508) | 2.82532604 |
| 106 | interferon-gamma secretion (GO:0072643) | 2.82054066 |
| 107 | macromolecular complex disassembly (GO:0032984) | 2.81789927 |
| 108 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.81514152 |
| 109 | nucleotide transmembrane transport (GO:1901679) | 2.81409001 |
| 110 | DNA geometric change (GO:0032392) | 2.81401795 |
| 111 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.80835739 |
| 112 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.80835739 |
| 113 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.80835739 |
| 114 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.80538496 |
| 115 | histone exchange (GO:0043486) | 2.79984626 |
| 116 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.78998941 |
| 117 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.78998941 |
| 118 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.78262668 |
| 119 | rRNA methylation (GO:0031167) | 2.78105945 |
| 120 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.77182504 |
| 121 | NIK/NF-kappaB signaling (GO:0038061) | 2.77085271 |
| 122 | mitotic chromosome condensation (GO:0007076) | 2.77058167 |
| 123 | * ncRNA processing (GO:0034470) | 2.76878858 |
| 124 | lymphocyte apoptotic process (GO:0070227) | 2.75973495 |
| 125 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.75074791 |
| 126 | necrotic cell death (GO:0070265) | 2.74919084 |
| 127 | tRNA modification (GO:0006400) | 2.74487578 |
| 128 | negative T cell selection (GO:0043383) | 2.71219148 |
| 129 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.71173775 |
| 130 | negative regulation of cell killing (GO:0031342) | 2.71173775 |
| 131 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.71061522 |
| 132 | regulation of metalloenzyme activity (GO:0048552) | 2.66803905 |
| 133 | T cell apoptotic process (GO:0070231) | 2.63486723 |
| 134 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.63336313 |
| 135 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.62924462 |
| 136 | cellular response to dsRNA (GO:0071359) | 2.60534794 |
| 137 | regulation of B cell apoptotic process (GO:0002902) | 2.59604034 |
| 138 | regulation of regulatory T cell differentiation (GO:0045589) | 2.59310111 |
| 139 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.56212197 |
| 140 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.55890674 |
| 141 | response to type I interferon (GO:0034340) | 2.51919292 |
| 142 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.51672264 |
| 143 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.51672264 |
| 144 | positive regulation of protein homooligomerization (GO:0032464) | 2.47863825 |
| 145 | rRNA catabolic process (GO:0016075) | 2.47394497 |
| 146 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.47116468 |
| 147 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.46779548 |
| 148 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.45248004 |
| 149 | cellular response to interleukin-15 (GO:0071350) | 2.40990574 |
| 150 | type I interferon signaling pathway (GO:0060337) | 2.40659707 |
| 151 | cellular response to type I interferon (GO:0071357) | 2.40659707 |
| 152 | leukocyte apoptotic process (GO:0071887) | 2.40562529 |
| 153 | mannose metabolic process (GO:0006013) | 2.40111223 |
| 154 | keratinocyte development (GO:0003334) | 2.37426976 |
| 155 | cytidine deamination (GO:0009972) | 2.36811036 |
| 156 | cytidine metabolic process (GO:0046087) | 2.36811036 |
| 157 | cytidine catabolic process (GO:0006216) | 2.36811036 |
| 158 | regulation of hippo signaling (GO:0035330) | 2.35498224 |
| 159 | natural killer cell activation (GO:0030101) | 2.32011631 |
| 160 | mitochondrial RNA metabolic process (GO:0000959) | 2.31004083 |
| 161 | regulation of cell killing (GO:0031341) | 2.30248172 |
| 162 | response to interleukin-15 (GO:0070672) | 2.29839050 |
| 163 | positive regulation of cell killing (GO:0031343) | 2.29109550 |
| 164 | thymic T cell selection (GO:0045061) | 2.28755793 |
| 165 | cellular response to interferon-beta (GO:0035458) | 2.27089137 |
| 166 | response to interferon-beta (GO:0035456) | 2.26906410 |
| 167 | regulation of memory T cell differentiation (GO:0043380) | 2.26564259 |
| 168 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.24906571 |
| 169 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.23819375 |
| 170 | regulation of histone H3-K27 methylation (GO:0061085) | 2.22837989 |
| 171 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.22356706 |
| 172 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.20676922 |
| 173 | cellular response to ATP (GO:0071318) | 2.20370527 |
| 174 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.20109025 |
| 175 | regulation of gamma-delta T cell activation (GO:0046643) | 2.19815691 |
| 176 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.19039889 |
| 177 | tRNA methylation (GO:0030488) | 2.16517407 |
| 178 | S-adenosylmethionine metabolic process (GO:0046500) | 2.16076236 |
| 179 | nucleotide-sugar metabolic process (GO:0009225) | 2.14870690 |
| 180 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.14402282 |
| 181 | cellular anion homeostasis (GO:0030002) | 2.14200764 |
| 182 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.13985876 |
| 183 | mannosylation (GO:0097502) | 2.12586923 |
| 184 | organelle membrane fusion (GO:0090174) | 2.12545387 |
| 185 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.12361825 |
| 186 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.11097661 |
| 187 | L-fucose catabolic process (GO:0042355) | 2.10597074 |
| 188 | fucose catabolic process (GO:0019317) | 2.10597074 |
| 189 | L-fucose metabolic process (GO:0042354) | 2.10597074 |
| 190 | regulation of chronic inflammatory response (GO:0002676) | 2.10215600 |
| 191 | RNA modification (GO:0009451) | 2.08599179 |
| 192 | positive regulation of T cell mediated immunity (GO:0002711) | 2.08255391 |
| 193 | T cell selection (GO:0045058) | 2.08253563 |
| 194 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.07988401 |
| 195 | cellular ketone body metabolic process (GO:0046950) | 2.07286453 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.41242677 |
| 2 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.37514448 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.19319325 |
| 4 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.19159144 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.18186416 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.12471726 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.02214087 |
| 8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.98236830 |
| 9 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.97466060 |
| 10 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.96480406 |
| 11 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.93741866 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.92831233 |
| 13 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.92521988 |
| 14 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.84735871 |
| 15 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.73569384 |
| 16 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.69710654 |
| 17 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.45739123 |
| 18 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.38629984 |
| 19 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.32311168 |
| 20 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.29643232 |
| 21 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.26997452 |
| 22 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.22978890 |
| 23 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.07917512 |
| 24 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.04513953 |
| 25 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.04216202 |
| 26 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.01309647 |
| 27 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.98968118 |
| 28 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.98289128 |
| 29 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.94540214 |
| 30 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.90405286 |
| 31 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.84588942 |
| 32 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.84090152 |
| 33 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.82512859 |
| 34 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.82384366 |
| 35 | MAF_26560356_Chip-Seq_TH1_Human | 1.81093592 |
| 36 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.78856957 |
| 37 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.77446438 |
| 38 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.76508549 |
| 39 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.75383812 |
| 40 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.73100326 |
| 41 | MYC_22102868_ChIP-Seq_BL_Human | 1.72250523 |
| 42 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70254825 |
| 43 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.70126247 |
| 44 | MAF_26560356_Chip-Seq_TH2_Human | 1.69033150 |
| 45 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.65001013 |
| 46 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.63034307 |
| 47 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.61650049 |
| 48 | MYB_26560356_Chip-Seq_TH1_Human | 1.61238515 |
| 49 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.60930374 |
| 50 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.58777637 |
| 51 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.56879993 |
| 52 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.55714224 |
| 53 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53764173 |
| 54 | MYB_26560356_Chip-Seq_TH2_Human | 1.53116295 |
| 55 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.52633461 |
| 56 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.51494532 |
| 57 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.50387023 |
| 58 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.50319310 |
| 59 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.49469619 |
| 60 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.46434369 |
| 61 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.45813104 |
| 62 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.45799416 |
| 63 | UTX_26944678_Chip-Seq_JUKART_Human | 1.45464654 |
| 64 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.44813853 |
| 65 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.40957409 |
| 66 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.40836996 |
| 67 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.40731287 |
| 68 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40327489 |
| 69 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.40309727 |
| 70 | P68_20966046_ChIP-Seq_HELA_Human | 1.39996808 |
| 71 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.39240652 |
| 72 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36917706 |
| 73 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.36906593 |
| 74 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.36011558 |
| 75 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.35291847 |
| 76 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.34395064 |
| 77 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.34124812 |
| 78 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.31625975 |
| 79 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.30594041 |
| 80 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.30311582 |
| 81 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.30085806 |
| 82 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.28901731 |
| 83 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.28525143 |
| 84 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.27760249 |
| 85 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27599169 |
| 86 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.26966251 |
| 87 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.23209108 |
| 88 | GATA3_26560356_Chip-Seq_TH2_Human | 1.20863921 |
| 89 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.20184252 |
| 90 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.19935484 |
| 91 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.19408917 |
| 92 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.19337761 |
| 93 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.18248966 |
| 94 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.17532550 |
| 95 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.17249347 |
| 96 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.16397935 |
| 97 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.15574440 |
| 98 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14581062 |
| 99 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.14230181 |
| 100 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13970022 |
| 101 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.13718516 |
| 102 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.13471340 |
| 103 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.13101831 |
| 104 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.12734519 |
| 105 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.11843521 |
| 106 | ATF3_27146783_Chip-Seq_COLON_Human | 1.11227775 |
| 107 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.11198948 |
| 108 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.09693268 |
| 109 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.09596065 |
| 110 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.09552831 |
| 111 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.08064619 |
| 112 | P300_27268052_Chip-Seq_Bcells_Human | 1.08016392 |
| 113 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.06946103 |
| 114 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.06434418 |
| 115 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.04593900 |
| 116 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.04218246 |
| 117 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.04076027 |
| 118 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.03473588 |
| 119 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.00375995 |
| 120 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00159448 |
| 121 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.99238215 |
| 122 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.99225305 |
| 123 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.98952230 |
| 124 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.98928228 |
| 125 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97724383 |
| 126 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.97329276 |
| 127 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.96626366 |
| 128 | ERA_21632823_ChIP-Seq_H3396_Human | 0.95305115 |
| 129 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94741408 |
| 130 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94689804 |
| 131 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.94585368 |
| 132 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.94459206 |
| 133 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.94278274 |
| 134 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.93934899 |
| 135 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.93784917 |
| 136 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93254040 |
| 137 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.91829399 |
| 138 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.90477089 |
| 139 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.90342696 |
| 140 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.90021372 |
| 141 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.89395208 |
| 142 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.88684600 |
| 143 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.88227788 |
| 144 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.87153579 |
| 145 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.86894960 |
| 146 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.82927450 |
| 147 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.81197436 |
| 148 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.79649847 |
| 149 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.79061618 |
| 150 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.77220713 |
| 151 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.76221762 |
| 152 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75655955 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 5.35123184 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 4.36877177 |
| 3 | MP0010094_abnormal_chromosome_stability | 4.29094437 |
| 4 | MP0003111_abnormal_nucleus_morphology | 4.21300180 |
| 5 | MP0003077_abnormal_cell_cycle | 4.03006155 |
| 6 | MP0008057_abnormal_DNA_replication | 3.91292963 |
| 7 | MP0001873_stomach_inflammation | 3.26058648 |
| 8 | MP0008058_abnormal_DNA_repair | 3.18224151 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.95613986 |
| 10 | MP0002396_abnormal_hematopoietic_system | 2.79926712 |
| 11 | MP0008007_abnormal_cellular_replicative | 2.77891514 |
| 12 | MP0002254_reproductive_system_inflammat | 2.62264858 |
| 13 | MP0010234_abnormal_vibrissa_follicle | 2.60953909 |
| 14 | MP0001986_abnormal_taste_sensitivity | 2.50104924 |
| 15 | MP0008932_abnormal_embryonic_tissue | 2.48080633 |
| 16 | MP0001730_embryonic_growth_arrest | 2.42984613 |
| 17 | MP0000350_abnormal_cell_proliferation | 2.18189517 |
| 18 | MP0010352_gastrointestinal_tract_polyps | 2.01151667 |
| 19 | MP0005310_abnormal_salivary_gland | 1.94358752 |
| 20 | MP0000490_abnormal_crypts_of | 1.90996311 |
| 21 | MP0003786_premature_aging | 1.89889454 |
| 22 | MP0008875_abnormal_xenobiotic_pharmacok | 1.89728256 |
| 23 | MP0003123_paternal_imprinting | 1.82932761 |
| 24 | MP0010307_abnormal_tumor_latency | 1.82585904 |
| 25 | MP0000015_abnormal_ear_pigmentation | 1.80952310 |
| 26 | MP0003186_abnormal_redox_activity | 1.78378221 |
| 27 | MP0005000_abnormal_immune_tolerance | 1.76583428 |
| 28 | MP0004381_abnormal_hair_follicle | 1.76071968 |
| 29 | MP0009333_abnormal_splenocyte_physiolog | 1.74558120 |
| 30 | MP0005397_hematopoietic_system_phenotyp | 1.73988160 |
| 31 | MP0001545_abnormal_hematopoietic_system | 1.73988160 |
| 32 | MP0003656_abnormal_erythrocyte_physiolo | 1.72253069 |
| 33 | MP0005387_immune_system_phenotype | 1.72046356 |
| 34 | MP0001790_abnormal_immune_system | 1.72046356 |
| 35 | MP0000427_abnormal_hair_cycle | 1.71468883 |
| 36 | MP0003718_maternal_effect | 1.71201187 |
| 37 | MP0002138_abnormal_hepatobiliary_system | 1.68361468 |
| 38 | MP0001348_abnormal_lacrimal_gland | 1.65202125 |
| 39 | MP0001697_abnormal_embryo_size | 1.61556798 |
| 40 | MP0002019_abnormal_tumor_incidence | 1.58845084 |
| 41 | MP0001672_abnormal_embryogenesis/_devel | 1.58156015 |
| 42 | MP0005380_embryogenesis_phenotype | 1.58156015 |
| 43 | MP0001661_extended_life_span | 1.56322374 |
| 44 | * MP0002080_prenatal_lethality | 1.56292833 |
| 45 | MP0000313_abnormal_cell_death | 1.53114567 |
| 46 | MP0002148_abnormal_hypersensitivity_rea | 1.52241323 |
| 47 | MP0003763_abnormal_thymus_physiology | 1.52143041 |
| 48 | MP0005083_abnormal_biliary_tract | 1.45779284 |
| 49 | MP0003984_embryonic_growth_retardation | 1.45666782 |
| 50 | MP0005174_abnormal_tail_pigmentation | 1.43337543 |
| 51 | MP0002088_abnormal_embryonic_growth/wei | 1.41893303 |
| 52 | MP0004947_skin_inflammation | 1.40528313 |
| 53 | MP0002419_abnormal_innate_immunity | 1.40427552 |
| 54 | MP0004808_abnormal_hematopoietic_stem | 1.40155800 |
| 55 | MP0002876_abnormal_thyroid_physiology | 1.38110204 |
| 56 | MP0002398_abnormal_bone_marrow | 1.37590706 |
| 57 | MP0005451_abnormal_body_composition | 1.34530860 |
| 58 | MP0006036_abnormal_mitochondrial_physio | 1.34256007 |
| 59 | MP0005075_abnormal_melanosome_morpholog | 1.34165293 |
| 60 | MP0000358_abnormal_cell_content/ | 1.32468546 |
| 61 | MP0000689_abnormal_spleen_morphology | 1.32403627 |
| 62 | MP0002722_abnormal_immune_system | 1.32077206 |
| 63 | MP0008877_abnormal_DNA_methylation | 1.31675067 |
| 64 | MP0001845_abnormal_inflammatory_respons | 1.30173484 |
| 65 | MP0003221_abnormal_cardiomyocyte_apopto | 1.27890742 |
| 66 | MP0006035_abnormal_mitochondrial_morpho | 1.27212867 |
| 67 | MP0006082_CNS_inflammation | 1.26647623 |
| 68 | MP0010155_abnormal_intestine_physiology | 1.25124628 |
| 69 | MP0003195_calcinosis | 1.23966111 |
| 70 | MP0002086_abnormal_extraembryonic_tissu | 1.23949394 |
| 71 | MP0000703_abnormal_thymus_morphology | 1.23861700 |
| 72 | MP0002085_abnormal_embryonic_tissue | 1.23706514 |
| 73 | MP0006054_spinal_hemorrhage | 1.22733441 |
| 74 | MP0004147_increased_porphyrin_level | 1.22149978 |
| 75 | MP0001533_abnormal_skeleton_physiology | 1.22065203 |
| 76 | MP0008469_abnormal_protein_level | 1.21907773 |
| 77 | MP0001853_heart_inflammation | 1.21631735 |
| 78 | MP0003567_abnormal_fetal_cardiomyocyte | 1.21086672 |
| 79 | MP0002084_abnormal_developmental_patter | 1.18891021 |
| 80 | MP0003866_abnormal_defecation | 1.16679000 |
| 81 | MP0003172_abnormal_lysosome_physiology | 1.16268917 |
| 82 | MP0005360_urolithiasis | 1.15956013 |
| 83 | MP0002132_abnormal_respiratory_system | 1.12239402 |
| 84 | MP0002429_abnormal_blood_cell | 1.11281724 |
| 85 | MP0000858_altered_metastatic_potential | 1.11168709 |
| 86 | MP0003950_abnormal_plasma_membrane | 1.09341696 |
| 87 | MP0004197_abnormal_fetal_growth/weight/ | 1.07561063 |
| 88 | MP0000371_diluted_coat_color | 1.06748777 |
| 89 | MP0003646_muscle_fatigue | 1.04848132 |
| 90 | MP0001835_abnormal_antigen_presentation | 1.04741706 |
| 91 | MP0005058_abnormal_lysosome_morphology | 1.04477231 |
| 92 | MP0002693_abnormal_pancreas_physiology | 1.01003399 |
| 93 | MP0003191_abnormal_cellular_cholesterol | 1.00329026 |
| 94 | MP0000609_abnormal_liver_physiology | 0.98945525 |
| 95 | MP0003890_abnormal_embryonic-extraembry | 0.98604275 |
| 96 | MP0002163_abnormal_gland_morphology | 0.97206280 |
| 97 | MP0000716_abnormal_immune_system | 0.96608027 |
| 98 | MP0005076_abnormal_cell_differentiation | 0.95025884 |
| 99 | MP0005379_endocrine/exocrine_gland_phen | 0.94686239 |
| 100 | MP0004233_abnormal_muscle_weight | 0.94419656 |
| 101 | MP0004043_abnormal_pH_regulation | 0.94328101 |
| 102 | MP0001216_abnormal_epidermal_layer | 0.94173540 |
| 103 | MP0000538_abnormal_urinary_bladder | 0.93324731 |
| 104 | MP0001293_anophthalmia | 0.92939563 |
| 105 | MP0005365_abnormal_bile_salt | 0.92822586 |
| 106 | MP0008872_abnormal_physiological_respon | 0.91176200 |
| 107 | MP0000685_abnormal_immune_system | 0.89796879 |
| 108 | MP0009764_decreased_sensitivity_to | 0.89106354 |
| 109 | MP0005266_abnormal_metabolism | 0.87951049 |
| 110 | MP0010329_abnormal_lipoprotein_level | 0.87785556 |
| 111 | MP0001800_abnormal_humoral_immune | 0.86939159 |
| 112 | MP0003045_fibrosis | 0.86693208 |
| 113 | MP0008961_abnormal_basal_metabolism | 0.86123857 |
| 114 | MP0004782_abnormal_surfactant_physiolog | 0.85648166 |
| 115 | MP0002210_abnormal_sex_determination | 0.85552748 |
| 116 | MP0005384_cellular_phenotype | 0.85291969 |
| 117 | MP0009643_abnormal_urine_homeostasis | 0.84650964 |
| 118 | MP0001944_abnormal_pancreas_morphology | 0.83505111 |
| 119 | MP0002970_abnormal_white_adipose | 0.83109276 |
| 120 | MP0009840_abnormal_foam_cell | 0.81325611 |
| 121 | MP0001765_abnormal_ion_homeostasis | 0.81172481 |
| 122 | MP0005332_abnormal_amino_acid | 0.80726447 |
| 123 | MP0005408_hypopigmentation | 0.80658858 |
| 124 | MP0000367_abnormal_coat/_hair | 0.80414071 |
| 125 | MP0010030_abnormal_orbit_morphology | 0.78991468 |
| 126 | MP0002405_respiratory_system_inflammati | 0.77293491 |
| 127 | MP0000470_abnormal_stomach_morphology | 0.77052046 |
| 128 | MP0002136_abnormal_kidney_physiology | 0.76891400 |
| 129 | MP0003436_decreased_susceptibility_to | 0.76272284 |
| 130 | MP0005621_abnormal_cell_physiology | 0.76209230 |
| 131 | MP0001145_abnormal_male_reproductive | 0.76020482 |
| 132 | MP0005671_abnormal_response_to | 0.74632590 |
| 133 | MP0002420_abnormal_adaptive_immunity | 0.73960279 |
| 134 | MP0001819_abnormal_immune_cell | 0.72571042 |
| 135 | MP0002452_abnormal_antigen_presenting | 0.71396577 |
| 136 | MP0005023_abnormal_wound_healing | 0.71315990 |
| 137 | MP0002723_abnormal_immune_serum | 0.71164419 |
| 138 | MP0009785_altered_susceptibility_to | 0.68789767 |
| 139 | MP0000598_abnormal_liver_morphology | 0.68264687 |
| 140 | MP0000477_abnormal_intestine_morphology | 0.67999576 |
| 141 | MP0001764_abnormal_homeostasis | 0.67480572 |
| 142 | MP0005025_abnormal_response_to | 0.64909518 |
| 143 | MP0001915_intracranial_hemorrhage | 0.64687044 |
| 144 | MP0009672_abnormal_birth_weight | 0.63315980 |
| 145 | MP0000653_abnormal_sex_gland | 0.63148796 |
| 146 | MP0009278_abnormal_bone_marrow | 0.62791636 |
| 147 | MP0001929_abnormal_gametogenesis | 0.62164983 |
| 148 | MP0004133_heterotaxia | 0.61766566 |
| 149 | MP0009379_abnormal_foot_pigmentation | 0.61495618 |
| 150 | MP0002166_altered_tumor_susceptibility | 0.60665069 |
| 151 | MP0002160_abnormal_reproductive_system | 0.60037946 |
| 152 | MP0001119_abnormal_female_reproductive | 0.59403472 |
| 153 | MP0003566_abnormal_cell_adhesion | 0.58618964 |
| 154 | MP0003315_abnormal_perineum_morphology | 0.57232084 |
| 155 | MP0000537_abnormal_urethra_morphology | 0.56324484 |
| 156 | MP0005501_abnormal_skin_physiology | 0.55830662 |
| 157 | MP0009053_abnormal_anal_canal | 0.55037966 |
| 158 | MP0008873_increased_physiological_sensi | 0.54683200 |
| 159 | MP0000750_abnormal_muscle_regeneration | 0.53031827 |
| 160 | MP0002111_abnormal_tail_morphology | 0.52745838 |
| 161 | MP0002006_tumorigenesis | 0.52156657 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.50989426 |
| 2 | Birth length less than 3rd percentile (HP:0003561) | 5.36965562 |
| 3 | Abnormal number of erythroid precursors (HP:0012131) | 5.33674287 |
| 4 | Reticulocytopenia (HP:0001896) | 4.59808010 |
| 5 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.41129139 |
| 6 | Oral leukoplakia (HP:0002745) | 3.95778666 |
| 7 | Breast hypoplasia (HP:0003187) | 3.80578660 |
| 8 | Aplastic anemia (HP:0001915) | 3.75106159 |
| 9 | Cerebral hypomyelination (HP:0006808) | 3.51554831 |
| 10 | Macrocytic anemia (HP:0001972) | 3.43120577 |
| 11 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.38184757 |
| 12 | Autoimmune hemolytic anemia (HP:0001890) | 3.37537795 |
| 13 | Increased IgM level (HP:0003496) | 3.25016487 |
| 14 | Pallor (HP:0000980) | 3.22186882 |
| 15 | Multiple enchondromatosis (HP:0005701) | 3.16009203 |
| 16 | Carpal bone hypoplasia (HP:0001498) | 3.14566587 |
| 17 | Stomatitis (HP:0010280) | 3.14019580 |
| 18 | Colon cancer (HP:0003003) | 3.12250658 |
| 19 | Rough bone trabeculation (HP:0100670) | 3.10807712 |
| 20 | Hypoalbuminemia (HP:0003073) | 3.07747778 |
| 21 | Abnormal albumin level (HP:0012116) | 3.07747778 |
| 22 | Pustule (HP:0200039) | 3.00360106 |
| 23 | Hypochromic anemia (HP:0001931) | 2.99887775 |
| 24 | Selective tooth agenesis (HP:0001592) | 2.98013148 |
| 25 | Autoimmune thrombocytopenia (HP:0001973) | 2.89594694 |
| 26 | Recurrent cutaneous fungal infections (HP:0011370) | 2.84376910 |
| 27 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.84376910 |
| 28 | Attenuation of retinal blood vessels (HP:0007843) | 2.83719458 |
| 29 | Thrombocytosis (HP:0001894) | 2.81004884 |
| 30 | Microretrognathia (HP:0000308) | 2.74266176 |
| 31 | Patellar aplasia (HP:0006443) | 2.74122052 |
| 32 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.72193215 |
| 33 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.72193215 |
| 34 | Recurrent fungal infections (HP:0002841) | 2.69468609 |
| 35 | Abnormality of the anterior horn cell (HP:0006802) | 2.68176263 |
| 36 | Degeneration of anterior horn cells (HP:0002398) | 2.68176263 |
| 37 | Gastrointestinal infarctions (HP:0005244) | 2.63126784 |
| 38 | Increased serum lactate (HP:0002151) | 2.59189487 |
| 39 | Vacuolated lymphocytes (HP:0001922) | 2.58869445 |
| 40 | Abnormality of T cell number (HP:0011839) | 2.55937552 |
| 41 | Hypoplasia of the pons (HP:0012110) | 2.55277318 |
| 42 | Agnosia (HP:0010524) | 2.55044174 |
| 43 | Myositis (HP:0100614) | 2.54855310 |
| 44 | Chromsome breakage (HP:0040012) | 2.53485663 |
| 45 | Premature ovarian failure (HP:0008209) | 2.53310322 |
| 46 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.53212824 |
| 47 | Abnormality of the preputium (HP:0100587) | 2.51691429 |
| 48 | Increased serum pyruvate (HP:0003542) | 2.50120262 |
| 49 | Abnormality of glycolysis (HP:0004366) | 2.50120262 |
| 50 | Abnormality of reticulocytes (HP:0004312) | 2.50119178 |
| 51 | Cellular immunodeficiency (HP:0005374) | 2.49982590 |
| 52 | Orchitis (HP:0100796) | 2.48995821 |
| 53 | Myelodysplasia (HP:0002863) | 2.48509956 |
| 54 | Abnormality of the pons (HP:0007361) | 2.48170083 |
| 55 | Premature graying of hair (HP:0002216) | 2.48103537 |
| 56 | Congenital stationary night blindness (HP:0007642) | 2.46196093 |
| 57 | Ependymoma (HP:0002888) | 2.45998176 |
| 58 | Retrobulbar optic neuritis (HP:0100654) | 2.45798692 |
| 59 | Optic neuritis (HP:0100653) | 2.45798692 |
| 60 | Trismus (HP:0000211) | 2.45788455 |
| 61 | Medulloblastoma (HP:0002885) | 2.45329038 |
| 62 | Secondary amenorrhea (HP:0000869) | 2.44600450 |
| 63 | Absent thumb (HP:0009777) | 2.42581399 |
| 64 | Pancytopenia (HP:0001876) | 2.42433496 |
| 65 | Cheilitis (HP:0100825) | 2.41081684 |
| 66 | Anorexia (HP:0002039) | 2.38744198 |
| 67 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.37575062 |
| 68 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.37169888 |
| 69 | Cutaneous melanoma (HP:0012056) | 2.35274411 |
| 70 | Neoplasm of the pancreas (HP:0002894) | 2.32361371 |
| 71 | Abnormality of chromosome stability (HP:0003220) | 2.31901352 |
| 72 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.31449456 |
| 73 | Abnormal trabecular bone morphology (HP:0100671) | 2.29790081 |
| 74 | Sparse lateral eyebrow (HP:0005338) | 2.25243949 |
| 75 | Meckel diverticulum (HP:0002245) | 2.23211038 |
| 76 | Testicular atrophy (HP:0000029) | 2.21776499 |
| 77 | Concave nail (HP:0001598) | 2.21299288 |
| 78 | Granulocytopenia (HP:0001913) | 2.21090552 |
| 79 | IgM deficiency (HP:0002850) | 2.20390384 |
| 80 | Rhabdomyosarcoma (HP:0002859) | 2.19159000 |
| 81 | Progressive muscle weakness (HP:0003323) | 2.18904417 |
| 82 | Increased hepatocellular lipid droplets (HP:0006565) | 2.18361458 |
| 83 | Lymphoma (HP:0002665) | 2.15402628 |
| 84 | Basal cell carcinoma (HP:0002671) | 2.15143041 |
| 85 | Megaloblastic anemia (HP:0001889) | 2.15033890 |
| 86 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.13253045 |
| 87 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.13078244 |
| 88 | Bone marrow hypocellularity (HP:0005528) | 2.12542650 |
| 89 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.12282098 |
| 90 | Hepatocellular necrosis (HP:0001404) | 2.12165134 |
| 91 | Abnormality of the ileum (HP:0001549) | 2.12000950 |
| 92 | Poor head control (HP:0002421) | 2.10122067 |
| 93 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.09372089 |
| 94 | CNS hypomyelination (HP:0003429) | 2.09356138 |
| 95 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.09114046 |
| 96 | Exertional dyspnea (HP:0002875) | 2.08768032 |
| 97 | Squamous cell carcinoma (HP:0002860) | 2.08718034 |
| 98 | Lipid accumulation in hepatocytes (HP:0006561) | 2.07847401 |
| 99 | Lip pit (HP:0100267) | 2.06063369 |
| 100 | Increased CSF lactate (HP:0002490) | 2.05657056 |
| 101 | Vascular calcification (HP:0004934) | 2.05174599 |
| 102 | Encephalitis (HP:0002383) | 2.03540365 |
| 103 | Eosinophilia (HP:0001880) | 2.02988817 |
| 104 | Vasculitis (HP:0002633) | 2.02074625 |
| 105 | Poikiloderma (HP:0001029) | 2.00555948 |
| 106 | Postnatal microcephaly (HP:0005484) | 1.99950164 |
| 107 | Panhypogammaglobulinemia (HP:0003139) | 1.99897206 |
| 108 | 11 pairs of ribs (HP:0000878) | 1.99877392 |
| 109 | Hepatic necrosis (HP:0002605) | 1.99831357 |
| 110 | Personality changes (HP:0000751) | 1.99559755 |
| 111 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.97537013 |
| 112 | Respiratory difficulties (HP:0002880) | 1.97278215 |
| 113 | Keratitis (HP:0000491) | 1.96938000 |
| 114 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.96696723 |
| 115 | Cleft eyelid (HP:0000625) | 1.95955120 |
| 116 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.95818781 |
| 117 | Nausea (HP:0002018) | 1.95182756 |
| 118 | Absent radius (HP:0003974) | 1.94330336 |
| 119 | Prostate neoplasm (HP:0100787) | 1.94256611 |
| 120 | Acute hepatic failure (HP:0006554) | 1.93142436 |
| 121 | Recurrent abscess formation (HP:0002722) | 1.90775468 |
| 122 | Abnormal protein glycosylation (HP:0012346) | 1.89706614 |
| 123 | Abnormal glycosylation (HP:0012345) | 1.89706614 |
| 124 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.89706614 |
| 125 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.89706614 |
| 126 | Spastic diplegia (HP:0001264) | 1.89695278 |
| 127 | Type I transferrin isoform profile (HP:0003642) | 1.89295791 |
| 128 | Impulsivity (HP:0100710) | 1.88966573 |
| 129 | Recurrent skin infections (HP:0001581) | 1.88749768 |
| 130 | Slender long bone (HP:0003100) | 1.88159651 |
| 131 | Abnormality of iron homeostasis (HP:0011031) | 1.88036220 |
| 132 | Mitochondrial inheritance (HP:0001427) | 1.87162451 |
| 133 | Amaurosis fugax (HP:0100576) | 1.86196153 |
| 134 | Sloping forehead (HP:0000340) | 1.85786197 |
| 135 | Abnormality of eosinophils (HP:0001879) | 1.85299993 |
| 136 | Easy fatigability (HP:0003388) | 1.85017112 |
| 137 | Recurrent bacterial skin infections (HP:0005406) | 1.84912666 |
| 138 | Clumsiness (HP:0002312) | 1.84391459 |
| 139 | Glucose intolerance (HP:0000833) | 1.84121894 |
| 140 | Alveolar cell carcinoma (HP:0006519) | 1.83902620 |
| 141 | Duodenal stenosis (HP:0100867) | 1.83810688 |
| 142 | Small intestinal stenosis (HP:0012848) | 1.83810688 |
| 143 | Hemoptysis (HP:0002105) | 1.83700085 |
| 144 | Horseshoe kidney (HP:0000085) | 1.83535610 |
| 145 | 3-Methylglutaconic aciduria (HP:0003535) | 1.82926962 |
| 146 | Tracheoesophageal fistula (HP:0002575) | 1.81721061 |
| 147 | CNS demyelination (HP:0007305) | 1.81060822 |
| 148 | Sparse eyelashes (HP:0000653) | 1.80338745 |
| 149 | Abnormality of T cell physiology (HP:0011840) | 1.80286593 |
| 150 | Hypertensive crisis (HP:0100735) | 1.79391098 |
| 151 | Pulmonary infiltrates (HP:0002113) | 1.78953156 |
| 152 | Ectropion (HP:0000656) | 1.78767717 |
| 153 | Keratoconjunctivitis (HP:0001096) | 1.77807915 |
| 154 | Abnormality of macrophages (HP:0004311) | 1.76875180 |
| 155 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.76175823 |
| 156 | Increased intramyocellular lipid droplets (HP:0012240) | 1.75967710 |
| 157 | Increased serum ferritin (HP:0003281) | 1.75741624 |
| 158 | Chronic diarrhea (HP:0002028) | 1.75558063 |
| 159 | Abnormality of T cells (HP:0002843) | 1.75410747 |
| 160 | Meningitis (HP:0001287) | 1.74849202 |
| 161 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.74633927 |
| 162 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.74633927 |
| 163 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.74633927 |
| 164 | Entropion (HP:0000621) | 1.73699093 |
| 165 | Absent forearm bone (HP:0003953) | 1.73511719 |
| 166 | Aplasia involving forearm bones (HP:0009822) | 1.73511719 |
| 167 | IgG deficiency (HP:0004315) | 1.72783286 |
| 168 | Malnutrition (HP:0004395) | 1.72455707 |
| 169 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.72282711 |
| 170 | Verrucae (HP:0200043) | 1.71971159 |
| 171 | Papilloma (HP:0012740) | 1.71971159 |
| 172 | Atresia of the external auditory canal (HP:0000413) | 1.71514691 |
| 173 | Lactic acidosis (HP:0003128) | 1.70939802 |
| 174 | Dysostosis multiplex (HP:0000943) | 1.69867339 |
| 175 | Abnormality of DNA repair (HP:0003254) | 1.69825780 |
| 176 | Ureteral duplication (HP:0000073) | 1.68816360 |
| 177 | Enlarged epiphyses (HP:0010580) | 1.68742849 |
| 178 | Arterial thrombosis (HP:0004420) | 1.67609486 |
| 179 | Chronic hepatic failure (HP:0100626) | 1.67543406 |
| 180 | Neutropenia (HP:0001875) | 1.66937232 |
| 181 | Ketosis (HP:0001946) | 1.66721597 |
| 182 | Neonatal hypoglycemia (HP:0001998) | 1.66394928 |
| 183 | Eczematoid dermatitis (HP:0000976) | 1.66385370 |
| 184 | Hypergonadotropic hypogonadism (HP:0000815) | 1.65967826 |
| 185 | Cardiovascular calcification (HP:0011915) | 1.65758917 |
| 186 | Opisthotonus (HP:0002179) | 1.63809732 |
| 187 | Abnormal glucose tolerance (HP:0001952) | 1.63652749 |
| 188 | Increased cerebral lipofuscin (HP:0011813) | 1.63400452 |
| 189 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.62886222 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.66754220 |
| 2 | FRK | 4.41580808 |
| 3 | WEE1 | 4.06080910 |
| 4 | CDC7 | 3.71516775 |
| 5 | EIF2AK1 | 3.53501044 |
| 6 | NME2 | 3.26018888 |
| 7 | ACVR1B | 2.86474833 |
| 8 | STK16 | 2.33175781 |
| 9 | NEK2 | 2.24159790 |
| 10 | TSSK6 | 2.12279660 |
| 11 | NEK1 | 2.11656938 |
| 12 | TRIB3 | 2.04296970 |
| 13 | EIF2AK3 | 2.03177548 |
| 14 | SRPK1 | 2.01053187 |
| 15 | MAP3K14 | 1.99838477 |
| 16 | TESK2 | 1.94297718 |
| 17 | SMG1 | 1.92847437 |
| 18 | BRSK2 | 1.90051627 |
| 19 | RPS6KA4 | 1.82937734 |
| 20 | TGFBR1 | 1.81472120 |
| 21 | MAP4K2 | 1.80459859 |
| 22 | PIM2 | 1.76094246 |
| 23 | VRK1 | 1.70421974 |
| 24 | SIK2 | 1.68962915 |
| 25 | TLK1 | 1.67689688 |
| 26 | TTK | 1.65627304 |
| 27 | IRAK3 | 1.64269603 |
| 28 | MAP4K1 | 1.63577809 |
| 29 | PLK1 | 1.62969776 |
| 30 | DYRK3 | 1.62269169 |
| 31 | SIK3 | 1.58733722 |
| 32 | CDK7 | 1.56031149 |
| 33 | AURKB | 1.53774631 |
| 34 | STK10 | 1.49881765 |
| 35 | PLK4 | 1.49573801 |
| 36 | RPS6KB2 | 1.47476587 |
| 37 | SCYL2 | 1.47436710 |
| 38 | MAP3K11 | 1.44747076 |
| 39 | AKT3 | 1.41577955 |
| 40 | MAP3K8 | 1.38987274 |
| 41 | ATR | 1.38445399 |
| 42 | EEF2K | 1.37008453 |
| 43 | TBK1 | 1.36798703 |
| 44 | IRAK4 | 1.34391946 |
| 45 | CDK4 | 1.29912418 |
| 46 | BRSK1 | 1.29740268 |
| 47 | MAP2K6 | 1.29541034 |
| 48 | ADRBK2 | 1.25588957 |
| 49 | MST1R | 1.24665539 |
| 50 | PDK2 | 1.23924970 |
| 51 | WNK4 | 1.22206510 |
| 52 | IKBKE | 1.21888861 |
| 53 | NUAK1 | 1.19761103 |
| 54 | AURKA | 1.18475785 |
| 55 | CHUK | 1.18260201 |
| 56 | MAP3K10 | 1.17690342 |
| 57 | PIK3CA | 1.15801084 |
| 58 | LRRK2 | 1.15082251 |
| 59 | BMPR2 | 1.14920204 |
| 60 | FLT3 | 1.14589309 |
| 61 | SIK1 | 1.12794868 |
| 62 | TAOK3 | 1.12633911 |
| 63 | PASK | 1.12152006 |
| 64 | CHEK2 | 1.11194701 |
| 65 | PAK4 | 1.09389362 |
| 66 | KDR | 1.09259526 |
| 67 | MAP2K3 | 1.07354633 |
| 68 | MKNK1 | 1.03480966 |
| 69 | PLK3 | 1.00723467 |
| 70 | CHEK1 | 0.96356468 |
| 71 | PIM1 | 0.93487457 |
| 72 | MAP2K2 | 0.92192161 |
| 73 | PKN2 | 0.91695350 |
| 74 | STK4 | 0.90750664 |
| 75 | BCKDK | 0.90621598 |
| 76 | INSRR | 0.90102196 |
| 77 | PRKD2 | 0.88309685 |
| 78 | VRK2 | 0.88265151 |
| 79 | CDK12 | 0.87755137 |
| 80 | ZAK | 0.87648533 |
| 81 | JAK1 | 0.85345970 |
| 82 | CDK8 | 0.82296716 |
| 83 | BLK | 0.80770508 |
| 84 | IRAK1 | 0.79349058 |
| 85 | ITK | 0.78560066 |
| 86 | CLK1 | 0.77008536 |
| 87 | JAK3 | 0.75673882 |
| 88 | CCNB1 | 0.74247422 |
| 89 | CSNK2A2 | 0.74022419 |
| 90 | LCK | 0.73741379 |
| 91 | TYK2 | 0.72007822 |
| 92 | STK39 | 0.71847726 |
| 93 | EPHA2 | 0.70622558 |
| 94 | RPS6KA5 | 0.69564346 |
| 95 | PAK1 | 0.69502154 |
| 96 | ZAP70 | 0.67748041 |
| 97 | CDK2 | 0.66484629 |
| 98 | LMTK2 | 0.66129025 |
| 99 | BRAF | 0.65268714 |
| 100 | MUSK | 0.65154185 |
| 101 | MAPKAPK3 | 0.65110567 |
| 102 | ATM | 0.64035207 |
| 103 | CSNK2A1 | 0.63937048 |
| 104 | PTK6 | 0.63459248 |
| 105 | TAOK2 | 0.62962697 |
| 106 | MELK | 0.60255698 |
| 107 | GRK1 | 0.59728194 |
| 108 | OXSR1 | 0.59418389 |
| 109 | FGFR4 | 0.56597586 |
| 110 | HCK | 0.56559077 |
| 111 | TRPM7 | 0.55222907 |
| 112 | ICK | 0.54866142 |
| 113 | FER | 0.54764240 |
| 114 | RAF1 | 0.54718325 |
| 115 | MAPK11 | 0.54315820 |
| 116 | GRK6 | 0.53898932 |
| 117 | MARK3 | 0.53222488 |
| 118 | EIF2AK2 | 0.52046763 |
| 119 | TNK2 | 0.51838820 |
| 120 | BTK | 0.51740258 |
| 121 | TESK1 | 0.50942896 |
| 122 | KIT | 0.50191662 |
| 123 | TEC | 0.50039870 |
| 124 | NME1 | 0.49828274 |
| 125 | SYK | 0.49293288 |
| 126 | ADRBK1 | 0.49026570 |
| 127 | MKNK2 | 0.48951854 |
| 128 | MST4 | 0.48481326 |
| 129 | PRKCQ | 0.48327266 |
| 130 | FGFR2 | 0.48298883 |
| 131 | ABL2 | 0.47487421 |
| 132 | CDK6 | 0.47101145 |
| 133 | ALK | 0.46728184 |
| 134 | CAMK1D | 0.46054652 |
| 135 | PTK2B | 0.45622009 |
| 136 | MAP3K3 | 0.45359231 |
| 137 | ILK | 0.44834958 |
| 138 | CSF1R | 0.44224715 |
| 139 | PRKCI | 0.43084197 |
| 140 | IRAK2 | 0.42580752 |
| 141 | PBK | 0.42575475 |
| 142 | CDK1 | 0.42188559 |
| 143 | LYN | 0.41283160 |
| 144 | PDPK1 | 0.39088019 |
| 145 | MAP3K5 | 0.38799627 |
| 146 | CAMKK2 | 0.38720204 |
| 147 | LATS2 | 0.37673733 |
| 148 | EPHB1 | 0.36379765 |
| 149 | AKT2 | 0.36049900 |
| 150 | ARAF | 0.35813771 |
| 151 | MAPKAPK2 | 0.35263055 |
| 152 | PDK3 | 0.34771832 |
| 153 | PDK4 | 0.34771832 |
| 154 | BRD4 | 0.34692218 |
| 155 | STK38 | 0.34508713 |
| 156 | LIMK1 | 0.34040444 |
| 157 | MAPK12 | 0.33220431 |
| 158 | TXK | 0.29240730 |
| 159 | IKBKB | 0.28292013 |
| 160 | ERN1 | 0.26928998 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.72625354 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.79321939 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 3.74181539 |
| 4 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.68947735 |
| 5 | Proteasome_Homo sapiens_hsa03050 | 3.58190823 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 3.27174253 |
| 7 | Spliceosome_Homo sapiens_hsa03040 | 3.02910763 |
| 8 | RNA transport_Homo sapiens_hsa03013 | 2.86639817 |
| 9 | Base excision repair_Homo sapiens_hsa03410 | 2.85121977 |
| 10 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.84541067 |
| 11 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.64971400 |
| 12 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.58930244 |
| 13 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.53916808 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 2.51522879 |
| 15 | Homologous recombination_Homo sapiens_hsa03440 | 2.49866419 |
| 16 | Cell cycle_Homo sapiens_hsa04110 | 2.25176601 |
| 17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.14682717 |
| 18 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.12152142 |
| 19 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.95627436 |
| 20 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.89357177 |
| 21 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.83308768 |
| 22 | RNA degradation_Homo sapiens_hsa03018 | 1.70686579 |
| 23 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.68343960 |
| 24 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.66702902 |
| 25 | Basal transcription factors_Homo sapiens_hsa03022 | 1.60746277 |
| 26 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.59561945 |
| 27 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.57343306 |
| 28 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.50627693 |
| 29 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.44484623 |
| 30 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.44053421 |
| 31 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.43876567 |
| 32 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.42334513 |
| 33 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.36180487 |
| 34 | Sulfur relay system_Homo sapiens_hsa04122 | 1.35315482 |
| 35 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.35062209 |
| 36 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.34982606 |
| 37 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.34078543 |
| 38 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.31990523 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.28926822 |
| 40 | Purine metabolism_Homo sapiens_hsa00230 | 1.28447443 |
| 41 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.28343393 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.27458576 |
| 43 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.24223728 |
| 44 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.23424777 |
| 45 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.16248074 |
| 46 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.16015338 |
| 47 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.15941269 |
| 48 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.14155912 |
| 49 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.12580274 |
| 50 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.11293937 |
| 51 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.10365558 |
| 52 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.09748606 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 1.07126798 |
| 54 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.04547696 |
| 55 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.02036439 |
| 56 | Carbon metabolism_Homo sapiens_hsa01200 | 1.01155956 |
| 57 | Insulin resistance_Homo sapiens_hsa04931 | 0.99950068 |
| 58 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.96690914 |
| 59 | Lysosome_Homo sapiens_hsa04142 | 0.96038739 |
| 60 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.95608665 |
| 61 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.91373663 |
| 62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.91088053 |
| 63 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.90683620 |
| 64 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.89945674 |
| 65 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.89162038 |
| 66 | ABC transporters_Homo sapiens_hsa02010 | 0.85849092 |
| 67 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.85807955 |
| 68 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.84115263 |
| 69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.83501514 |
| 70 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.82095107 |
| 71 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.79387186 |
| 72 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.76958918 |
| 73 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.76626971 |
| 74 | Parkinsons disease_Homo sapiens_hsa05012 | 0.76479664 |
| 75 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.75415112 |
| 76 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.73488738 |
| 77 | Huntingtons disease_Homo sapiens_hsa05016 | 0.72666799 |
| 78 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.71233313 |
| 79 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69896544 |
| 80 | Protein export_Homo sapiens_hsa03060 | 0.68454036 |
| 81 | Lysine degradation_Homo sapiens_hsa00310 | 0.68103809 |
| 82 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.66574251 |
| 83 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.66413255 |
| 84 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.66228366 |
| 85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.65629978 |
| 86 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.60914420 |
| 87 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.60008570 |
| 88 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.58353953 |
| 89 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.57003694 |
| 90 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.56298584 |
| 91 | Legionellosis_Homo sapiens_hsa05134 | 0.55564813 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51877102 |
| 93 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.51755072 |
| 94 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.49188431 |
| 95 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.49099653 |
| 96 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48212087 |
| 97 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.47398200 |
| 98 | Tuberculosis_Homo sapiens_hsa05152 | 0.46132899 |
| 99 | Thyroid cancer_Homo sapiens_hsa05216 | 0.44316315 |
| 100 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43939807 |
| 101 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.43578864 |
| 102 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.42737496 |
| 103 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.42078519 |
| 104 | Apoptosis_Homo sapiens_hsa04210 | 0.41891548 |
| 105 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.41784468 |
| 106 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.41697202 |
| 107 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40788645 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.40571424 |
| 109 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.40340742 |
| 110 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.39978534 |
| 111 | Measles_Homo sapiens_hsa05162 | 0.37771236 |
| 112 | Leishmaniasis_Homo sapiens_hsa05140 | 0.37360093 |
| 113 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.37081701 |
| 114 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.36461359 |
| 115 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35726884 |
| 116 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.35080517 |
| 117 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.35007366 |
| 118 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34779362 |
| 119 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34455105 |
| 120 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.33213329 |
| 121 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31611711 |
| 122 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.31000471 |
| 123 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.30256694 |
| 124 | Shigellosis_Homo sapiens_hsa05131 | 0.28985019 |
| 125 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.27562649 |
| 126 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.27377026 |
| 127 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.27182461 |
| 128 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.27135618 |
| 129 | Alcoholism_Homo sapiens_hsa05034 | 0.24925316 |
| 130 | Hepatitis B_Homo sapiens_hsa05161 | 0.24877408 |
| 131 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.22392393 |
| 132 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.20710530 |
| 133 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.20053673 |
| 134 | Bladder cancer_Homo sapiens_hsa05219 | 0.18235497 |
| 135 | Influenza A_Homo sapiens_hsa05164 | 0.17769292 |
| 136 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.17483989 |
| 137 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.15164237 |
| 138 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.14746486 |
| 139 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.13654692 |
| 140 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.13249189 |
| 141 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.12669522 |
| 142 | Alzheimers disease_Homo sapiens_hsa05010 | 0.12179109 |
| 143 | Allograft rejection_Homo sapiens_hsa05330 | 0.11573375 |
| 144 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.11419214 |
| 145 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.11382497 |
| 146 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.09422242 |
| 147 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.09404008 |
| 148 | Colorectal cancer_Homo sapiens_hsa05210 | 0.09281133 |
| 149 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.08007827 |
| 150 | Viral myocarditis_Homo sapiens_hsa05416 | 0.07857768 |
| 151 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.07689445 |

